PTH and prostate carcinoma: Previous studies in prostate cancer models have reported that in animals with subcutaneous tumours receiving a daily administration of PTH for three weeks, increased numbers of tumour cells were recovered from the mandible, rib, spine and tibia, but not from femurs, compared to control [27].